Joseph Romanelli - Net Worth and Insider Trading

Joseph Romanelli Net Worth

The estimated net worth of Joseph Romanelli is at least $3 Million dollars as of 2024-02-23. Joseph Romanelli is the President, Human Health Int?l of Merck & Co Inc and owns about 19,569 shares of Merck & Co Inc (MRK) stock worth over $3 Million. Details can be seen in Joseph Romanelli's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joseph Romanelli has not made any transactions after 2024-02-13 and currently still holds the listed stock(s).

Transaction Summary of Joseph Romanelli

To

Joseph Romanelli Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joseph Romanelli owns 2 companies in total, including Merck & Co Inc () , and Merck & Co Inc () .

Click here to see the complete history of Joseph Romanelli’s form 4 insider trades.

Insider Ownership Summary of Joseph Romanelli

Ticker Comapny Transaction Date Type of Owner
Merck & Co Inc 2024-02-13 President & Human Health Int?l
Merck & Co Inc 2022-07-18 President & Human Health Int?l

Joseph Romanelli Latest Holdings Summary

Joseph Romanelli currently owns a total of 1 stock. Joseph Romanelli owns 19,569 shares of Merck & Co Inc (MRK) as of February 13, 2024, with a value of $3 Million.

Latest Holdings of Joseph Romanelli

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MRK Merck & Co Inc 2024-02-13 19,569 129.45 2,533,207

Holding Weightings of Joseph Romanelli


Joseph Romanelli Form 4 Trading Tracker

According to the SEC Form 4 filings, Joseph Romanelli has made a total of 5 transactions in Merck & Co Inc (MRK) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Merck & Co Inc is the sale of 1,000 shares on February 13, 2024, which brought Joseph Romanelli around $124,890.

Insider Trading History of Joseph Romanelli

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joseph Romanelli Trading Performance

GuruFocus tracks the stock performance after each of Joseph Romanelli's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph Romanelli is -5.55%. GuruFocus also compares Joseph Romanelli's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph Romanelli within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Joseph Romanelli's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Joseph Romanelli

Average Relative Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -2.08 -5.55 -6.95
Relative Return to S&P 500(%) -5.76 -18.14 -8.95

Joseph Romanelli Ownership Network

Ownership Network List of Joseph Romanelli

No Data

Ownership Network Relation of Joseph Romanelli


Joseph Romanelli Owned Company Details

What does Merck & Co Inc do?

Who are the key executives at Merck & Co Inc?

Joseph Romanelli is the President & Human Health Int?l of Merck & Co Inc. Other key executives at Merck & Co Inc include Evp & Global Svcs & CFO Robert M Davis , EVP & CFO Caroline Litchfield , and Executive VP & President & MRL Dean Y Li .

Merck & Co Inc () Insider Trades Summary

Over the past 18 months, Joseph Romanelli made 5 insider transaction in Merck & Co Inc () with a net sale of 5,715. Other recent insider transactions involving Merck & Co Inc () include a net sale of 133,401 shares made by Steven Mizell , a net sale of 72,029 shares made by Johannes Jacobus Oosthuizen , and a net sale of 2,172,853 shares made by Kenneth C Frazier .

In summary, during the past 3 months, insiders sold 309,424 shares of Merck & Co Inc () in total and bought 0 shares, with a net sale of 309,424 shares. During the past 18 months, 3,968,347 shares of Merck & Co Inc () were sold and 409 shares were bought by its insiders, resulting in a net sale of 3,967,938 shares.

Merck & Co Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Merck & Co Inc Insider Transactions

No Available Data

Joseph Romanelli Mailing Address

Above is the net worth, insider trading, and ownership report for Joseph Romanelli. You might contact Joseph Romanelli via mailing address: 126 East Lincoln Avenue, Rahway Nj 07065.

Discussions on Joseph Romanelli

No discussions yet.